
Monique Roobol, PhD, MSc, noted that approximately half of the 30% higher incidence of prostate cancer in the screened arm represents overdiagnosis, primarily of low-risk cancers.
Roobol is an epidemiologist, a professor of Decision Making in Urology, and the head of the scientific research office within the department of urology at Erasmus Medical Center in Rotterdam, Netherlands.